OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Challenges of Implementing Alternative Delivery Models for Genetic Counseling in Prostate Cancer

May 14th 2020

Alanna K. Rahm, PhD, MS, discusses the challenges of implementing alternate delivery models for genetic counseling in prostate cancer.

Dr. Iyer on TRAEs With Erdafitinib in Urothelial Cancer

May 14th 2020

Gopa Iyer, MD, discusses treatment-related adverse events (TRAEs) with erdafitinib (Balversa) in urothelial cancer.

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma

May 14th 2020

Andrew Branagan, MD, discusses the results of the phase 3 TOURMALINE-MM3 trial in multiple myeloma.

Dr. Pagel on the Implications of Polatuzumab Vedotin Approval in DLBCL

May 13th 2020

John M. Pagel, MD, PhD, discusses the implications of the FDA approval of polatuzumab vedotin in diffuse large B-cell lymphoma.

Challenges of Implementing Alternative Delivery Models for Genetic Counseling in Prostate Cancer

May 13th 2020

Alanna K. Rahm, PhD, MS, discusses the challenges of implementing alternative delivery models for genetic counseling in prostate cancer.

Dr. Smith on Frontline Treatment Options in MCL

May 13th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC

May 13th 2020

Hope S. Rugo, MD, discusses takeaways from the phase 3 IMpassion130 trial in metastatic triple-negative breast cancer.

Dr. Gayle on Current Treatment Options in Breast Implant-Associated ALCL

May 13th 2020

Lloyd B. Gayle, MD, discusses current treatment options for patients who develop breast implant–associated anaplastic large cell lymphoma (ALCL).

Dr. Niu on Combining Immunotherapy With VEGF Inhibitors in ES-SCLC

May 13th 2020

Jiaxin (Jason) Niu, MD, PhD, discusses combining immunotherapy with VEGF Inhibitors in extensive-stage small cell lung cancer.

Dr. Patel on the Clinical Implications of Luspatercept Approval in MDS

May 13th 2020

Prapti Patel, MD, discusses the clinical implications of the FDA approval of luspatercept-aamt in myelodysplastic syndrome.

Dr. Carbone on the Importance of Personalizing Immunotherapy in NSCLC

May 13th 2020

David P. Carbone, MD, PhD, discusses the importance of personalizing immunotherapy for patients with non–small cell lung cancer.

Dr. Goy on the Evolution of Treatment Selection in MCL

May 13th 2020

Andre Goy, MD, MS, discusses the evolution of treatment selection in mantle cell lymphoma.

Dr. Gerson on Clinical Trial Accrual in MCL

May 13th 2020

James N. Gerson, MD, discusses clinical trial accrual in mantle cell lymphoma.

Dr. Heath on Developments in Nonmetastatic CRPC

May 13th 2020

Elisabeth I. Heath, MD, FACP, discusses developments in nonmetastatic castration-resistant prostate cancer (CRPC).

Dr. Trent on the Impact of COVID-19 on the Treatment of Rare Cancers

May 13th 2020

Jonathan C. Trent, MD, PhD, sheds light on the impact of COVID-19 on the treatment of rare cancers.

Dr. Braunstein on Updated Results of the GRIFFIN Trial in Multiple Myeloma

May 13th 2020

Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.

Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors

May 13th 2020

John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.

Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors

May 12th 2020

John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.

Dr. Patel on the Clinical Implications of Luspatercept Approval in MDS

May 12th 2020

Prapti Patel, MD, discusses the clinical implications of the FDA approval of luspatercept-aamt in myelodysplastic syndrome.